Compugen Ltd CGEN-IL:Tel Aviv Stock Exchange

*Data is delayed | Exchange | ILS
Last | 05/02/24 EEST
760.00UNCH (UNCH)
52 week range
641.20 - 1,175.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close760.00
  • 52 Week High1,175.00
  • 52 Week High Date03/05/24
  • 52 Week Low641.20
  • 52 Week Low Date01/07/24

Key Stats

  • Market Cap172.79M
  • Shares Out89.53M
  • 10 Day Average Volume154,588.57
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change7.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close760.00
  • 52 Week High1,175.00
  • 52 Week High Date03/05/24
  • 52 Week Low641.20
  • 52 Week Low Date01/07/24
  • Market Cap172.79M
  • Shares Out89.53M
  • 10 Day Average Volume154,588.57
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change7.95

RATIOS/PROFITABILITY

  • EPS (TTM)-77.74
  • P/E (TTM)-9.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Compugen Ltd

 

Profile

MORE
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs...
Paul Sekhri
Non-Executive Independent Chairman of the Board
Anat Cohen-Dayag Ph.D.
President, Chief Executive Officer, Director
Ari Krashin CPA
Chief Financial Officer, Chief Operating Officer
Eran Ophir
Vice President - Research, Drug Discovery
Address
Azrieli Center, 26 Harokmim St. Bldg D
Holon
5885849
Israel